Bridging the Diversity Gap with Decentralized Trials

The current drug development research paradigm is flawed in that it fails to include a diverse and representative patient population. A new approach that begins with a patient-centric mindset, coupled with the use of mobile technology and connected health platforms, will enable research to become less reliant on site-based visits and bring equal access to new investigational therapies for all patients, regardless of geography, ethnicity, sex, or gender.

In this white paper, you will learn about: 

• The current diversity gap and limitations in clinical research
• Barriers for underrepresented patient populations
• Breaking barriers with patient-centric approaches and advanced technology
• Foundations for a new clinical research model
• Engaging and protecting patients with technology


2 International Place #2610

Boston, MA 02110-4104